Cancer-Med    What are we doing?
    Sitting on our backsides   -  waiting for someone to come along and give a hand? We don't think that would be right at all. So instead we are hyperactive in development, promotion, logistics, training and delivery.
    Cancer-Med is a program with a single purpose - to bring a new and revolutionary tool to patients and the medical community in their fight against cancer (and other diseases where the extremely high selectivity of co-bodies can be of benefit). For this to happen soon, we must engage in essential background activities of which the first and not least is finance.

    Finance and CanChure
     The CanChure program is one avenue and is especially important because the inner nature of our system makes it unpalatable to major pharmaceutical companies. Co-bodies are not like a neat little synthetic chemical for mass-manufacture and mass distribution, sold retail as a medicine at one hundred times base cost.

    Research and Logistics
    You will find more about our research activities on the Progress and Research pages. Soon (hopefully very soon) attention will switch to building up the facilities for providing co-bodies to those who need them, when and where they are needed. Our system is a family of thousands or even millions of different co-bodies, tailored to suit the individual cancer of the individual patient by combining two, three or four selected antibodies out of thousands held in stock. The requirements are modest by high-tech medical standards but it still means secure cold-storage and small, specially designed laboratories, strategically placed around the world.

    Training
    The testing and final assembly steps are not intrinsically difficult, do not require industrial organisation: no special equipment is required, just knowledge and training   -   another reason why big Pharma is unsympathetic. But it still has to be prepared for and will cost money.

    Promotion
     And nothing will happen without promotion. That's why we are happy to travel around the world to give lectures and talk with prospective partners. The thing is important because no-one else is doing it and the product is necessary for diagnosis and treatment of patients. The potential is colossal.